Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthgrades for Professionals
Recent survey findings reveal that nearly one-third of adults aged 60 and older take daily aspirin for primary prevention of heart disease, despite updated guidelines advising against it for those without prior cardiovascular events.
Cardiology July 9th 2024
Medical News Today (MNT)
The introduction of the PREVENT equations could reduce the number of adults eligible for statin therapy by nearly 40%, impacting clinical guidelines and patient care strategies.
Cardiology June 20th 2024
MDLinx
A phase 3 trial demonstrates that aficamten improves oxygen utilization during exercise for obstructive HCM patients, indicating its potential to enhance daily functionality and quality of life.
Cardiology June 18th 2024
Annals of Internal Medicine
This study evaluates the use of statins for primary prevention of cardiovascular diseases in adults aged 75 years and older, demonstrating a significant reduction in CVD incidence without an increase in severe adverse events. These findings provide real-world evidence to guide clinical decision-making in this underrepresented population.
Cardiology June 5th 2024
Lower baseline testosterone and hormonal imbalances, including low SHBG and DHT levels, are significantly associated with increased all-cause and cardiovascular mortality in aging men.
Cardiology May 20th 2024
Cleveland Clinic Journal of Medicine (CCJM)
Cardiac amyloidosis often presents with nonspecific symptoms and requires a high index of suspicion and specialized diagnostic protocols to ensure accurate diagnosis and effective management.
Cardiology May 16th 2024